LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 21 of 497
Next
>>
>
501 to 525 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	GSK1059615	0.12	uM	LJP6	3	C05	72	hr	1097	2220	3769	0.5889	0.4201
BT-20	GSK1904529A	0.12	uM	LJP6	1	H23	72	hr	1097	3259	3769	0.8646	0.8090
BT-20	GSK1904529A	0.12	uM	LJP6	2	H23	72	hr	1097	3461	3769	0.9182	0.8845
BT-20	GSK1904529A	0.12	uM	LJP6	3	H23	72	hr	1097	3147	3769	0.8349	0.7670
BT-20	Omipalisib	0.12	uM	LJP6	1	N05	72	hr	1097	765	3769	0.2029	-0.1243
BT-20	Omipalisib	0.12	uM	LJP6	2	N05	72	hr	1097	694	3769	0.1841	-0.1509
BT-20	Omipalisib	0.12	uM	LJP6	3	N05	72	hr	1097	728	3769	0.1931	-0.1382
BT-20	GSK 690693	0.12	uM	LJP5	1	F23	72	hr	1097	2816	3769	0.7470	0.6432
BT-20	GSK 690693	0.12	uM	LJP5	2	F23	72	hr	1097	3002	3769	0.7964	0.7128
BT-20	GSK 690693	0.12	uM	LJP5	3	F23	72	hr	1097	2899	3769	0.7691	0.6742
BT-20	GW843682X	0.12	uM	LJP6	1	B17	72	hr	1097	2133	3769	0.5659	0.3876
BT-20	GW843682X	0.12	uM	LJP6	2	B17	72	hr	1097	2391	3769	0.6343	0.4841
BT-20	GW843682X	0.12	uM	LJP6	3	B17	72	hr	1097	1999	3769	0.5303	0.3374
BT-20	HG-5-113-01	0.12	uM	LJP5	1	B11	72	hr	1097	3232	3769	0.8574	0.7989
BT-20	HG-5-113-01	0.12	uM	LJP5	2	B11	72	hr	1097	3551	3769	0.9420	0.9182
BT-20	HG-5-113-01	0.12	uM	LJP5	3	B11	72	hr	1097	3672	3769	0.9741	0.9635
BT-20	HG-5-88-01	0.12	uM	LJP6	1	A23	72	hr	1097	3372	3769	0.8945	0.8512
BT-20	HG-5-88-01	0.12	uM	LJP6	2	A23	72	hr	1097	3592	3769	0.9529	0.9336
BT-20	HG-5-88-01	0.12	uM	LJP6	3	A23	72	hr	1097	3511	3769	0.9314	0.9033
BT-20	Imatinib	0.12	uM	LJP6	1	N17	72	hr	1097	3600	3769	0.9550	0.9366
BT-20	Imatinib	0.12	uM	LJP6	2	N17	72	hr	1097	3755	3769	0.9961	0.9946
BT-20	Imatinib	0.12	uM	LJP6	3	N17	72	hr	1097	3983	3769	1.0566	1.0799
BT-20	JNK-9L	0.12	uM	LJP6	1	K23	72	hr	1097	3105	3769	0.8237	0.7513
BT-20	JNK-9L	0.12	uM	LJP6	2	K23	72	hr	1097	2805	3769	0.7441	0.6391
BT-20	JNK-9L	0.12	uM	LJP6	3	K23	72	hr	1097	3006	3769	0.7975	0.7143

|<
<<
Previous
Page 21 of 497
Next
>>
>
501 to 525 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)